Efficacy and safety of switching from Eculizumab to Ravulizumab for the maintenance of aHUS remission after kidney transplant: a preliminary experience

J Nephrol. 2024 Nov;37(8):2421-2423. doi: 10.1007/s40620-024-02005-7. Epub 2024 Jul 16.

Marco Busutti^#¹, Federica Maritati^#¹, Greta Borelli¹, Claudia Bini¹, Valeria Corradetti¹, Vania Cuna¹, Chiara Abenavoli^{1

2}, Michele Provenzano^{1

2}, Matteo Ravaioli^{2

3}, Gaetano La Manna^{4

5}, Giorgia Comai^{1

2}

¹ Nephrology, Dialysis and Kidney Transplant Unit, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Via Massarenti 13, 40138, Bologna, Italy.
² Department of Medical and Surgical Science (DIMEC), Alma Mater Studiorum University of Bologna, Bologna, Italy.
³ Hepato-Biliary Surgery and Transplant Unit, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italy.
⁴ Nephrology, Dialysis and Kidney Transplant Unit, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Via Massarenti 13, 40138, Bologna, Italy. [email protected].
⁵ Department of Medical and Surgical Science (DIMEC), Alma Mater Studiorum University of Bologna, Bologna, Italy. [email protected].

^# Contributed equally.

No abstract available

Publication types